相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Amplification of HER2 is a marker for global genomic instability
Rachel E. Ellsworth et al.
BMC CANCER (2008)
New cutpoints to identify increased HER2 copy number: analysis of a large, population-based cohort with long-term follow-up
K. C. Jensen et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Current issues in ER and HER2 testing by IHC in breast cancer
Allen M. Gown
MODERN PATHOLOGY (2008)
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases
Dmitry A. Turbin et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Comparing subjective and digital image analysis HER2/neu expression scores with conventional and modified FISH scores in breast cancer
I. Skaland et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American society of clinical Oncology/College of American pathologists guidelines:: tumor heterogeneity in breast cancer and its implications for tissue Microarray based assessment of outcome
Christopher B. Moeder et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Semi-automated imaging system to quantitate Her-2/neu membrane receptor immunoreactivity in human breast cancer
Aparna S. Joshi et al.
CYTOMETRY PART A (2007)
A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2 status in breast cancer:: Comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility
William C. Powell et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
HER2 testing: a review of detection methodologies and their clinical performance
Jennifer Laudadio et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2007)
Refinement of immunohistologic parameters for Her2/neu scoring validation by FISH and CISH
Anthony S-Y Leong et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2006)
High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer:: A multicentre GEFPICS study
Magali Lacroix-Triki et al.
EUROPEAN JOURNAL OF CANCER (2006)
Quantification of immunohistochemistry - issues concerning methods, utility and semiquantitative assessment I
R. A. Walker
HISTOPATHOLOGY (2006)
Quantification of immunohistochemistry - issues concerning methods, utility and semiquantitative assessment II
C. R. Taylor et al.
HISTOPATHOLOGY (2006)
HER-2 status in breast cancer - Correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system
Armando Ciampa et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2006)
Selecting antibodies to detect HER2 overexpression by immunohistochemistry in invasive mammary carcinomas
AP Gouvêa et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2006)
Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in-situ hybridization in the evaluation of HER-2/neu expression in primary breast carcinoma
OW Tawfik et al.
HISTOPATHOLOGY (2006)
Analytical validation and interobserver reproducibility of EnzMet GenePro - A second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breast
E Downs-Kelly et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest™ in breast carcinoma
R Ainsworth et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
HER2 amplification status in breast cancer: a comparison between immunohistochemical staining and fluorescence in situ hybridisation using manual and automated quantitative image analysis scoring techniques
CM Ellis et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice
M Dolan et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Role of HER2/neu in tumor progession and therapy
S Ménard et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
The use of cell line standards to reduce HER-2/neu assay variation in multiple European Cancer Centers and the potential of automated image analysis to provide for more accurate cut points for predicting clinical response to trastuzumab
A Rhodes et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy
K Bloom et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Dysregulation of cellular signaling by HER2/neu in breast cancer
BP Zhou et al.
SEMINARS IN ONCOLOGY (2003)
Which breast carcinomas need HER-2/neu gene study after immunohistochemical analysis?: Results of combined use of antibodies against different c-erbB2 protein domains
A Sapino et al.
HISTOPATHOLOGY (2003)
Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer
N Makretsov et al.
HUMAN PATHOLOGY (2003)
Calibration of immunohistochemistry for assessment of HER2 in breast cancer:: results of the French Multicentre GEFPICS Study
A Vincent-Salomon et al.
HISTOPATHOLOGY (2003)
The HER-2/neu gene and protein in breast cancer 2003: Biomarker and target of therapy
JS Ross et al.
ONCOLOGIST (2003)
Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays
CL Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831
PC Roche et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Evaluation of interobserver agreement in scoring immunohistochemical results of HER-2/neu (c-erbB-2) expression detected by HercepTest, Nichirei polyclonal antibody, CB11 and TAB250 in breast carcinoma
H Tsuda et al.
PATHOLOGY INTERNATIONAL (2002)
HER-2/neu in breast cancer:: Interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization
TA Thomson et al.
MODERN PATHOLOGY (2001)
Update on HER-2 as a target for cancer therapy - Intracellular signaling pathways of ErbB2/HER-2 and family members
MA Olayioye
BREAST CANCER RESEARCH (2001)
Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: Apparent immunohistochemical false-positives do not get the message
RR Tubbs et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Concordance in judgments among c-erbB-2 (HER2/neu) overexpression detected by two immunohistochemical tests and gene amplification detected by Southern blot hybridization in breast carcinoma
H Tsuda et al.
PATHOLOGY INTERNATIONAL (2001)
Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTest(TM) in breast carcinoma by image analysis
Y Hatanaka et al.
PATHOLOGY INTERNATIONAL (2001)
Time course of chromatic adaptation for color appearance and discrimination
O Rinner et al.
VISION RESEARCH (2000)
分享论文
